Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers
Open Access
- 27 September 2019
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 17 (1) , 1-14
Abstract
Background: DNA methylation can regulate the role of long noncoding RNAs (lncRNAs) in the development of lung adenocarcinoma (LUAD). The present study aimed to identify methylation-driven lncRNAs and mRNAs as biomarkers in the prognosis of LUAD using bioinformatics analysis. Methods: Differentially expressed RNAs were obtained using the edge R package from 535 LUAD tissues and 59 adjacent non-LUAD tissues. Differentially methylated genes were obtained using the limma R package from 475 LUAD tissues and 32 adjacent non-LUAD tissues. Methylation-driven mRNA and lncRNA were obtained using the MethylMix R package from 465 LUAD tissues with matched DNA methylation and RNA expression and 32 non-LUAD tissues with DNA methylation. Gene ontology and ConsensusPathDB pathway analysis were performed to identify functional enrichment of methylation-driven mRNAs. Univariate and multivariate Cox regression analyses were performed to identify the independent effect of each variable for predicting the prognosis of LUAD. Kaplan–Meier curve analysis of DNA methylation and gene expression might provide potential prognostic biomarkers for LUAD patients. Results: A total of 99 methylation-driven mRNAs and 17 methylation-driven lncRNAs were obtained. Univariate and multivariate Cox regression analysis showed that 6 lncRNAs (FOXE1, HOXB13-AS1_2, VMO1, HIST1H3F, AJ003147.8, ASXL3) were retrieved to construct a predictive model associated with overall survival in LUAD patients. Combined DNA methylation and gene expression survival analysis revealed that 4 lncRNAs (AC023824.1, AF186192.1, LINC01354 and WASIR2) and 8 mRNAs (S1PR1, CCDC181, F2RL1, EFS, KLHDC9, MPV17L, GKN2, ITPRIPL1) might act as independent biomarkers for the prognosis of LUAD. Conclusions: Methylation-driven lncRNA and mRNA contribute to the survival of LUAD, and 4 lncRNAs and 8 mRNAs might be potential biomarkers for the prognosis of LUAD.Keywords
Funding Information
- Major Scientific and Technological Innovation Project of Shandong Province (2018CXGC1212)
- Science and Technology Foundation of Shandong Province (2014GSF118084), 2016GSF121043)
- Medical and Health Technology Innovation Plan of Ji'nan City (201805002)
- National Natural Science Foundation of China (81372333)
This publication has 53 references indexed in Scilit:
- Epigenetics Meets Genetics in Acute Myeloid Leukemia: Clinical Impact of a Novel Seven-Gene ScoreJournal of Clinical Oncology, 2014
- Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expressionBMC Cancer, 2013
- Long non-coding RNAs: A new frontier in the study of human diseasesCancer Letters, 2013
- Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinomaJournal of Molecular Histology, 2013
- Long noncoding RNA-mediated maintenance of DNA methylation and transcriptional gene silencingDevelopment, 2012
- Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung CancerCancer Discovery, 2011
- Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I casesLaboratory Investigation, 2011
- Long Interspersed Nuclear Element 1 Hypomethylation Is a Marker of Poor Prognosis in Stage IA Non–Small Cell Lung CancerClinical Cancer Research, 2010
- Mpv17l protects against mitochondrial oxidative stress and apoptosis by activation of Omi/HtrA2 proteaseProceedings of the National Academy of Sciences, 2008
- Rules for Making Human Tumor CellsNew England Journal of Medicine, 2002